Novartis Investigative Site

Włocławek 87-800

0 studies enrolling now · 3 studies all time

What they study most

Acute Heart Failure, Atherosclerosis, Atherosclerotic Cardiovascular Disease

Studies at this site

• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed
• Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed